Skip to content
healthcare.dev
Get a free key

Bupropion Hydrobromide

NDC 68682-582, Bupropion Hydrobromide, tablet, extended release, from Oceanside Pharmaceuticals.

Product NDC
68682-582
Status
Listed
Labeler
Oceanside Pharmaceuticals
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022108
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68682-582 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROBROMIDE522 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
68682-582-306868205823030 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-582-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3ec04240-baef-44d7-8d73-a181171eec43

Use it

Look up 68682-582 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68682-582 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68682-582. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.